Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants.
Sign Up to like & getrecommendations! Published in 2025 at "Clinical pharmacology in drug development"
DOI: 10.1002/cpdd.1611
Abstract: Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two-treatment-period, drug-drug interaction study evaluated the effect of steady-state asciminib on the… read more here.
Keywords: healthy participants; asciminib atorvastatin; drug interaction; drug ... See more keywords